CCL2 and COVID-19: Subsequently, Paxlovid was analyzed against the core targets of LUAD/COVID-19 (CXCL2, CCL2, IL12B, CSF3, LBP, IL6, CXCL10) and Paxlovid, and the results showed that IL-6, IL12B, LBP and Paxlovid could be combined.